BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Meng LL, Di YP, Ma L, Qu BL. Advances in prostate cancer treatment with moderate and ultra-hypofractionated radiotherapy. World J Clin Oncol 2025; 16(12): 112735 [PMID: 41480171 DOI: 10.5306/wjco.v16.i12.112735]
URL: https://www.wjgnet.com/2218-4333/full/v16/i12/112735.htm
(30) (38) (0) (0) (7) (846) (1)
Number Citing Articles
1
Nada Samir Shams El-Din El-Behiri, Mohamed A Alm El-Din, Asmaa Mohamed Alkady, Rabab Mahmoud Moussa, Mohamed Mohamed Elshebeny. Hypofractionated versus conventional IMRT in unfavorable intermediate- and high-risk prostate cancer: A phase II comparative study of PSA kinetics, dosimetric and toxicity outcomes. The French Journal of Urology 2026; 36(5) doi: 10.1016/j.fjurol.2026.103104
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.